MDAKX Performance — NYLI Moderate ETF Allocation Fund, Class C
Data updated: 2026-09-23
MDAKX returned +6.52% year to date and +13.49% over one year to Jul 2026. Annualised returns are +10.50% over 3 years and +5.28% over 5 years. Against its Alternative category average the fund came out behind over three years but ahead over one: $100 invested three years ago grew to $135, against $168 for the category, and to $113 over one year, against $108. Volatility over the past three years was 9.22% a year. In the 12 months to Jul 2026 the fund took in a net $24.6M, and assets reached $216.65M.
MDAKX Growth of $100
What $100 invested in NYLI Moderate ETF Allocation Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Alternative category average over the same months.
| Period | MDAKX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $113 | $108 |
| 3 years (Aug 2023 – Jul 2026) | $135 | $168 |
| 5 years (Aug 2021 – Jul 2026) | $129 | $159 |
| Since data start (Jul 2020 – Jul 2026) | $158 | $189 |
MDAKX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +6.52% |
| 1 year | +13.49% |
| 3 years (annualised) | +10.50% |
| 5 years (annualised) | +5.28% |
MDAKX Annual Returns
Calendar-year total returns of NYLI Moderate ETF Allocation Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +6.52% |
| 2025 | +12.94% |
| 2024 | +9.06% |
| 2023 | +12.79% |
| 2022 | −14.46% |
| 2021 | +10.00% |
| 2020 (Jul–Dec) | +13.20% |
MDAKX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +1.9% | +1.0% | −4.2% | +6.0% | +2.9% | +0.2% | −1.1% | — | — | — | — | — |
| 2025 | +2.0% | −0.7% | −2.6% | +0.2% | +3.3% | +3.1% | +0.6% | +2.0% | +2.4% | +1.4% | +0.4% | +0.3% |
| 2024 | +0.1% | +1.7% | +2.3% | −3.5% | +3.3% | +1.0% | +2.4% | +1.3% | +2.1% | −1.6% | +3.6% | −3.6% |
| 2023 | +5.5% | −2.4% | +1.3% | +0.5% | −1.5% | +3.9% | +2.1% | −1.8% | −3.7% | −2.6% | +6.7% | +4.7% |
| 2022 | −4.1% | −1.4% | +0.8% | −6.2% | +0.6% | −6.7% | +6.1% | −3.4% | −7.1% | +5.2% | +5.3% | −3.3% |
| 2021 | −0.6% | +1.1% | +1.7% | +2.8% | +1.1% | +0.6% | +0.8% | +1.2% | −3.0% | +3.4% | −1.9% | +2.7% |
| 2020 | — | — | — | — | — | — | +3.4% | +3.0% | −1.9% | −1.6% | +7.3% | +2.6% |
MDAKX Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 9.22%
- 3-year Sharpe ratio: 0.65 (vs 4.5% risk-free rate)
- Best month: +6.74% (Nov 2023)
- Worst month: −4.22% (Mar 2026)
MDAKX Fund Flows
Monthly money in and out of NYLI Moderate ETF Allocation Fund, from SEC Form N-PORT.
- 12-month net flow: $24.6M
- 12-month gross sales (incl. reinvestments): $53.2M
- Sales ÷ redemptions: 1.86×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $3.8M | $2.1M | $1.7M |
| Jun 2026 | $4.4M | $2.4M | $2.0M |
| May 2026 | $3.6M | $2.3M | $1.4M |
| Apr 2026 | $5.3M | $2.9M | $2.4M |
| Mar 2026 | $4.9M | $2.4M | $2.5M |
| Feb 2026 | $3.3M | $2.7M | $640K |
| Jan 2026 | $4.5M | $2.0M | $2.4M |
| Dec 2025 | $11.3M | $2.4M | $9.0M |
| Nov 2025 | $2.6M | $1.8M | $822K |
| Oct 2025 | $3.0M | $3.2M | −$235K |
| Sep 2025 | $4.0M | $2.0M | $2.0M |
| Aug 2025 | $2.6M | $2.5M | $59K |
MDAKX Assets Under Management
Net assets of NYLI Moderate ETF Allocation Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $216.65M |
| 2026-04-30 | $207.06M |
| 2026-01-31 | $196.08M |
| 2025-10-31 | $185.43M |
| 2025-07-31 | $173.12M |
| 2025-04-30 | $158.52M |
| 2025-01-31 | $160.46M |
| 2024-10-31 | $152.03M |
| 2024-07-31 | $146.42M |
| 2024-04-30 | $133.93M |
| 2024-01-31 | $126.00M |
| 2023-10-31 | $109.18M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.